Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials

American Journal of Clinical Nutrition

Volumn 88, Issue 1, 2008, Pages 38-50

  Hooper, Lee ^a   Kroon, Paul A ^b   Rimm, Eric B ^c   Cohn, Jeffrey S ^d   Harvey, Ian ^a   Le Cornu, Kathryn A ^a   Ryder, Jonathan J ^a   Hall, Wendy L ^e   Cassidy, Aedín ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HEART RESEARCH INSTITUTE   (Australia)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; FLAVANONE; FLAVONOID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CACAO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; FOOD INTAKE; HUMAN; META ANALYSIS; NUTRITIONAL ASSESSMENT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TEA;

CAMELLIA SINENSIS; THEOBROMA CACAO;

EID: 46649098436     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/88.1.38     Document Type: Article

References (68)

1. Erdman JW, Balentine D, Arab L, et al. Flavonoids and heart health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007;137(suppl):718S-37S.
2. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995;155:381-6.
3. Knekt P, Jarvinen R, Reunanen A, et al. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996;312:478-81.
4. Knekt P, Kumpulainen J, Jarvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002;76:560-8.
5. Yochum L, Kushi LH, Meyer K, et al. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999;149:943-9.
6. Arts IC, Jacobs DR Jr, Harnack LJ, et al. Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology 2001;12:668-75.
7. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997;349:699.
8. Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
9. Geleijnse JM, Launer LJ, Van der Kuip DA, et al. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002;75:880-6.
10. Hertog MG, Sweetnam PM, Fehily AM, et al. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997;65:1489-94.
11. Sesso HD, Gaziano JM, Liu S, et al. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 2003;77:1400-8.
12. Rimm EB, Katan MB, Ascherio A, et al. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996;125:384-9.
13. Lin J, Rexrode KM, Hu F, et al. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol 2007;165:1305-13.
14. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85:895-909.
15. Higgins JPT, Green S, eds. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane handbook for systematic reviews of interventions 4.2.5 (updated May 2005); Appendix 5b. The Cochrane Library, Issue 3, 2005. Chichester, UK: Wiley & Sons, Ltd. 2005.
16. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 2007;137:1244-52.
17. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006;55:1-12.
18. Cooper KA, Campos-Gimenez E, Jimenez Alvarez D, Nagy K, Donovan JL, Williamson G. Rapid reversed phase ultra-performance liquid chromatography analysis of the major cocoa polyphenols and interrelationships of their concentrations in chocolate. J Agric Food Chem 2007;55:2841-7.
19. Peterson J, Dwyer JT, Bhagwat S. Major flavonoids in dry tea. J Food Comp Anal 2005;18:487-501.
20. Gu D, Kelm MA, Hammerstone JF, et al. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 2004;134:613-7.
21. Auger C, Al-Awwadi N, Bornet A, et al. Catechins and procyanidins in Mediterranean diets. Food Res Int 2004;37:233-45.
22. Fletcher RJ. Food sources of phyto-oestrogens and their precursors in Europe. Br J Nutr 2003;89:S39-43.
23. Sanchez-Moreno C, Cao G, Ou B, Prior RL. Anthocyanin and proanthocyanidin content in selected white and red wines. Oxygen radical absorbance capacity comparison with nontraditional wines obtained from highbush blueberry. J Agric Food Chem 2003;51:4889-96.
24. Burns J, Gardner PT, O'Neil J. Relationship among antioxidant activity, vasodilation capacity, and phenolic content of red wines. J Agric Food Chem 2000;48:220-30.
25. Mukamal KJ, Rimm EB. Alcohol's effects on the risk for coronary heart disease. Alcohol Res Health: J Natl Inst Alcohol Abuse Alcoholism 2001;25:255-61.
26. McFadden CB, Brensinger CM, Berlin JA, Townsend RR. Systematic review of the effect of daily alcohol intake on blood pressure. Am J Hypertens 2005;18:276-86.
27. British Cardiac Society, British Hypertension Society, Diabetes UK, et al. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91 suppl 5:v1-52.
28. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
29. Witte DR, Westerink J, de Koning DJ, van der Graff Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol 2005;45:1987-93.
30. Brevetti G, Silvestro A, Schiano V, Chiarello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003;108:2093-8.
31. Chan SY, Mancini GBJ, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003;42:1037-43.
32. Shimbo D, Grahame-Clarke C, Miyake Y, et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007;192:197-203.
33. Yeboah J, Crouse JR, Hsu F-C, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007;115:2390-7.
34. Analysing and reporting results. In: Higgins JP, Green S, eds. Cochrane handbook for systematic reviews of interventions 8.7.2 (updated May 2005). The Cochrane Library, Issue 2, 2007. Chichester, UK: Wiley & Sons Ltd, 2005.
35. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002;31:140-9.
36. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
38. Heiss C, Finis D, Kleinbongard P, et al. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol 2007;49:74-80.
39. Schroeter H, Heiss C, Balzer J, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 2006;103:1024-9.
40. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M. Vascular effects of cocoa rich in flavan-3-ols[6]. JAMA 2003;290:1030-1.
41. Hermann F, Spieker LE, Ruschitzka F, et al. Dark chocolate improves endothelial and platelet function. Heart 2006;92:119-20.
42. Farouque HM, Leung M, Hope SA, et al. Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci 2006;111:71-80.
43. Grassi D, Necozione S, Lippi C, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilatation in hypertensives. Hypertension 2005;46:398-405.
44. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005;23:921-8.
45. Brown CA, Bolton-Smith C, Woodward M, et al. Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. J Epidemiol Community Health 1993;47:171-5.
46. Keli SO, Hertog MG, Feskens EJ, et al. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996;156:637-42.
47. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation 2002;105:2476-81.
48. Arts IC, Hollman PC, Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005;81(suppl):317S-25S.
49. Vita JA, Vita JA. Tea consumption and cardiovascular disease: effects on endothelial function. J Nutr 2003;133(suppl):3293S-7S.
50. Sesso HD, Gaziano JM, Buring JE, et al. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 1999;149:162-7.
51. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001;154:495-503.
52. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Medicine 2007;4:e5.
53. Taubert D, Roesen R, Schalmig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 2007;167:626-34.
54. Zhuo XG, Melby MK, Watanabe S, Zhuo XG, Melby MK, Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr 2004;134:2395-400.
55. Zhan S, Ho SC, Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005;81:397-408.
56. Balk E, Chung M, Chew P. Effects of soy on health outcomes. Rockville, MD: Agency for Healthcare Research and Quality, 2005.
57. Yeung J, Yu T-F. Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J 2003;2:15-9.
58. Taku U, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 2007;85:1148-56.
59. Cassidy A, Hooper L. Phytoestrogens and cardiovascular disease. J Br Menopause Soc 2007;12:49-56.
60. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81(suppl):230S-42S.
61. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005;81(suppl):243S-55S.
62. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-84.
63. Wang J, Mazza G. Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-gamma-activated RAW 264.7 macrophages. J Agric Food Chem 2002;50:850-7.
64. Hall WL, Rimbach G, Williams CM. Isoflavones and endothelial function. Nutr Res Rev 2005;18:130-44.
65. Kroon PA, Clifford MN, Crozier A, et al. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 2004;81:15-21.
66. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002;288:1882-8.
67. Gould AL, Davies GM, Alemao E, Yin DD, Cook JR. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther 2007;29:778-94.
68. US Department of Health and Human Services and US Department of Agriculture. Dietary guidelines for Americans. Washington, DC: Government Printing Office, 2005.